(-0.15%) 5 204.75 points
(-0.11%) 39 151 points
(-0.22%) 18 146 points
(0.43%) $79.33
(0.23%) $2.19
(0.01%) $2 322.60
(1.07%) $27.90
(0.64%) $990.90
(0.09%) $0.931
(0.23%) $10.92
(0.10%) $0.801
(0.28%) $91.99
Live Chart Being Loaded With Signals
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally...
Stats | |
---|---|
Today's Volume | 88 674.00 |
Average Volume | 781 891 |
Market Cap | 48.87B |
EPS | INR0 ( 2024-02-12 ) |
Next earnings date | ( INR0 ) 2024-05-23 |
Last Dividend | INR1.100 ( 2022-09-19 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -4 997.50 |
ATR14 | INR0.649 (0.13%) |
Volume Correlation
Shilpa Medicare Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shilpa Medicare Limited Correlation - Currency/Commodity
Shilpa Medicare Limited Financials
Annual | 2022 |
Revenue: | INR10.50B |
Gross Profit: | INR6.34B (60.39 %) |
EPS: | INR-3.74 |
FY | 2022 |
Revenue: | INR10.50B |
Gross Profit: | INR6.34B (60.39 %) |
EPS: | INR-3.74 |
FY | 2022 |
Revenue: | INR11.40B |
Gross Profit: | INR7.56B (66.31 %) |
EPS: | INR7.26 |
FY | 2021 |
Revenue: | INR9.00B |
Gross Profit: | INR6.29B (69.92 %) |
EPS: | INR18.13 |
Financial Reports:
No articles found.
Shilpa Medicare Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR1.100 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.233 | 2010-09-16 |
Last Dividend | INR1.100 | 2022-09-19 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | INR8.48 | -- |
Avg. Dividend % Per Year | 0.10% | -- |
Score | 0.67 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0.700 | 0.15% |
2019 | INR1.000 | 0.26% |
2020 | INR1.100 | 0.39% |
2021 | INR1.100 | 0.25% |
2022 | INR1.100 | 0.19% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
COROMANDEL.NS | Dividend Knight | 2023-07-13 | Annually | 19 | 1.02% | |
SHANTIGEAR.NS | Dividend Junior | 2023-07-11 | Annually | 23 | 1.02% | |
MANALIPETC.NS | Dividend Junior | 2023-09-15 | Annually | 18 | 1.50% | |
GPPL.NS | Dividend Knight | 2023-07-26 | Semi-Annually | 9 | 2.89% | |
AXISBANK.NS | Dividend Junior | 2023-07-06 | Sporadic | 26 | 0.06% | |
TTKPRESTIG.NS | Dividend Junior | 2023-07-21 | Annually | 20 | 0.43% | |
PKTEA.NS | Dividend Junior | 2023-09-18 | Sporadic | 15 | 0.24% | |
JKLAKSHMI.NS | Dividend Junior | 2023-08-11 | Annually | 18 | 0.50% | |
DHRUV.NS | Dividend Junior | 2023-09-05 | Insufficient data to determine frequency | 2 | 0.15% | |
SOMANYCERA.NS | Dividend Junior | 2023-08-18 | Annually | 23 | 0.39% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.000597 | 1.500 | -0.0119 | -0.0179 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.000377 | 1.500 | -1.115 | -1.673 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.259 | 1.000 | -0.645 | -0.645 | [3 - 30] |
operatingCashFlowPerShareTTM | 24.64 | 2.00 | 1.787 | 3.57 | [0 - 30] |
freeCashFlowPerShareTTM | 24.64 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.644 | 1.000 | 2.60 | 2.60 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0957 | 1.000 | -0.0864 | -0.0864 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.346 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -6 657.36 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.000377 | 2.50 | -0.717 | -1.673 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 24.64 | 2.00 | 1.787 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 24.64 | 2.00 | 1.787 | 3.57 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -604.79 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.190 | 1.000 | 7.74 | 0 | [0.1 - 0.5] |
Total Score | -0.690 |
Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators